✦ LIBER ✦

Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment

✍ Scribed by D. van de Vijver; R. Roos; P. Jansen; A. Porsius; A. de Boer

Publisher: Springer
Year: 2002
Tongue: English
Weight: 81 KB
Volume: 58
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-002-0441-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Coincidence of Schizophrenia and Idi

The Coincidence of Schizophrenia and Idiopathic Parkinson's Disease: Successful Treatment with a Combination of Antiparkinsonian Drugs and Atypical Antipsychotic Drugs

✍ MASAYUKI WATANABE; YOSHIO KODAMA; KUNIO SHIMIZU; NAOMICHI ICHINOWATARI 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

It is rare for schizophrenia and idiopathic Parkinson's disease to occur in the same patient. This report describes a case in which a chronic schizophrenic patient later developed idiopathic Parkinson's disease. Both the psychotic and the parkinsonian symptoms of the patient were well controlled wit

Atypical antipsychotics in the treatment

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

✍ Joseph H. Friedman; Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Pharmacokinetic and Pharmacodynamic Chan

Pharmacokinetic and Pharmacodynamic Changes During the First Four Years of Levodopa Treatment in Parkinson’s Disease

✍ Phylinda L. S. Chan; John G. Nutt; Nicholas H. G. Holford 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 219 KB

Metabolic control and vascular diseases

Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD

✍ Georg Biesenbach; Gert Bodlaj; Stephan Ebner; Peter Biesenbach; Herwig Pieringer 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 198 KB

One year study of efficacy and safety of

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugs

✍ AnnaRita Giardina; Angelo Ferrante; Francesco Ciccia; Maria Vadalà; Ennio Giardi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB